Evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/ IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs.

Original languageEnglish
Pages (from-to)611-615
Number of pages5
JournalInfection and Chemotherapy
Volume52
Issue number4
DOIs
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020 by The Korean Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibody
  • Chikungunya
  • Diagnostic performance
  • Infection
  • Lateral flow immunoassay

Fingerprint

Dive into the research topics of 'Evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus'. Together they form a unique fingerprint.

Cite this